Works matching IS 09650407 AND DT 2024 AND VI 32 AND IP 3

Results: 12

Role of oncogenic long noncoding RNA KCNQ1OT1 in colon cancer.

Published in:

Oncology Research, 2024, v. 32, n. 3, p. 585, doi. 10.32604/or.2023.029349

By:

GANG LIU;
LEI SHI;
BIN WANG;
ZEHUI WU;
HAIYUAN ZHAO;
TIANYU ZHAO;
LIANGHUI SHI

Publication type:

Article

Bone marrow microRNA-34a is a good indicator for response to treatment in acute myeloid leukemia.

Published in:

Oncology Research, 2024, v. 32, n. 3, p. 577, doi. 10.32604/or.2023.043026

By:

ABDELLATEIF, MONA S.;
HASSAN, NAGLAA M.;
KAMEL, MAHMOUD M.;
EL-MELIGUI, YOMNA M.

Publication type:

Article

Glycogen metabolism-mediated intercellular communication in the tumor microenvironment influences liver cancer prognosis.

Published in:

Oncology Research, 2024, v. 32, n. 3, p. 563, doi. 10.32604/or.2023.029697

By:

YANG ZHANG;
NANNAN QIN;
XIJUN WANG;
RUI LIANG;
QUAN LIU;
RUOYI GENG;
TIANXIAO JIANG;
YUNFEI LIU;
JINWEI LI

Publication type:

Article

Low expression of fatty acid oxidation related gene ACADM indicates poor prognosis of renal clear cell carcinoma and is related to tumor immune infiltration.

Published in:

Oncology Research, 2024, v. 32, n. 3, p. 545, doi. 10.32604/or.2023.030462

By:

JIECHUAN QIU;
TIANMIN YANG;
YANNING SUN;
KAI SUN;
YINGKUN XU;
QINGHUA XIA

Publication type:

Article

CircTHSD4 promotes the malignancy and docetaxel (DTX) resistance in prostate cancer by regulating miR-203/HMGA2 axis.

Published in:

Oncology Research, 2024, v. 32, n. 3, p. 529, doi. 10.32604/or.2023.031511

By:

JIANYUN XIE;
LINJIE LU;
JIALI ZHANG;
QIRUI LI;
WEIDONG CHEN

Publication type:

Article

MicroRNA (let-7b-5p)-targeted DARS2 regulates lung adenocarcinoma growth by PI3K/AKT signaling pathway.

Published in:

Oncology Research, 2024, v. 32, n. 3, p. 517, doi. 10.32604/or.2023.030293

By:

YUANYUAN XU;
XIAOKE CHEN

Publication type:

Article

Gastric cancer secretedmiR-214-3p inhibits the anti-angiogenesis effect of apatinib by suppressing ferroptosis in vascular endothelial cells.

Published in:

Oncology Research, 2024, v. 32, n. 3, p. 489, doi. 10.32604/or.2023.046676

By:

WEIXUE WANG;
TONGTONG WANG;
YAN ZHANG;
TING DENG;
HAIYANG ZHANG;
YI BA

Publication type:

Article

Pan-cancer analysis of RNA 5-methylcytosine reader (ALYREF).

Published in:

Oncology Research, 2024, v. 32, n. 3, p. 503, doi. 10.32604/or.2024.045050

By:

XING YE;
ZHOUTING TUO;
KAI CHEN;
RUICHENG WU;
JIE WANG;
QINGXIN YU;
LUXIA YE;
AKIRA MIYAMOTO;
KOO HAN YOO;
CHI ZHANG;
WURAN WEI;
DENGXIONG LI;
DECHAO FENG

Publication type:

Article

The anti-neoplastic effects of metformin modulate the acquired phenotype of fibroblast cells in the breast cancer-normal fibroblast co-culture system.

Published in:

Oncology Research, 2024, v. 32, n. 3, p. 477, doi. 10.32604/or.2023.043926

By:

MOSTAFAVI, SAMANEH;
HASSAN, ZUHAIR MOHAMMAD

Publication type:

Article

MicroRNA-329-3p inhibits the Wnt/Î²-catenin pathway and proliferation of osteosarcoma cells by targeting transcription factor 7-like 1.

Published in:

Oncology Research, 2024, v. 32, n. 3, p. 463, doi. 10.32604/or.2023.044085

By:

HUI SUN;
MASANORI KAWANO;
TATSUYA IWASAKI;
ICHIRO ITONAGA;
YUTA KUBOTA;
HIROSHI TSUMURA;
KAZUHIRO TANAKA

Publication type:

Article

A review of the literature on the use of CRISPR/Cas9 gene therapy to treat hepatocellular carcinoma.

Published in:

Oncology Research, 2024, v. 32, n. 3, p. 439, doi. 10.32604/or.2023.044473

By:

AMJAD, ELHAM;
PEZZANI, RAFFAELE;
SOKOUTI, BABAK

Publication type:

Article

Stem cell technology for antitumor drug loading and delivery in oncology.

Published in:

Oncology Research, 2024, v. 32, n. 3, p. 433, doi. 10.32604/or.2023.046497

By:

PETRELLA, FRANCESCO;
CASSINA, ENRICO MARIO;
LIBRETTI, LIDIA;
PIRONDINI, EMANUELE;
RAVEGLIA, FEDERICO;
TUORO, ANTONIO

Publication type:

Article